Margaret A. Chang

Margaret A. Chang

Ophthalmology

Sacramento, CA 95825

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Operating Room Access: Survey of the American Society of Retina Specialists.

Operating Room Access: Survey of the American Society of Retina Specialists.

Journal: Journal of vitreoretinal diseases

Published: June 15, 2026

MAGIC: Study Design and Rationale for the Phase 2 Clinical Trial of Faricimab for Non-Proliferative Diabetic Retinopathy.

MAGIC: Study Design and Rationale for the Phase 2 Clinical Trial of Faricimab for Non-Proliferative Diabetic Retinopathy.

Journal: Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde

Published: June 13, 2025

Structural Updates to the Implant and Refill Needle of the Port Delivery Platform.

Structural Updates to the Implant and Refill Needle of the Port Delivery Platform.

Journal: Translational vision science & technology

Published: April 07, 2025

Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial.

Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial.

Journal: JAMA ophthalmology

Published: March 06, 2025

Extended Intraocular Drug-Delivery Platforms for the Treatment of Retinal and Choroidal Diseases.

Extended Intraocular Drug-Delivery Platforms for the Treatment of Retinal and Choroidal Diseases.

Journal: Journal of vitreoretinal diseases

Published: September 25, 2024

Endophthalmitis in Eyes Treated with the Port Delivery System with Ranibizumab: Summary of Cases during Clinical Trial Development.

Endophthalmitis in Eyes Treated with the Port Delivery System with Ranibizumab: Summary of Cases during Clinical Trial Development.

Journal: Ophthalmology. Retina

Published: May 01, 2024

Interim Results of the Phase III Portal Extension Trial of the Port Delivery System with Ranibizumab in Neovascular Age-Related Macular Degeneration.

Interim Results of the Phase III Portal Extension Trial of the Port Delivery System with Ranibizumab in Neovascular Age-Related Macular Degeneration.

Journal: Ophthalmology. Retina

Published: March 01, 2024

Vision Loss Reduction with Avacincaptad Pegol for Geographic Atrophy: A 12-Month Post Hoc Analysis of the GATHER1 and GATHER2 Trials.

Vision Loss Reduction with Avacincaptad Pegol for Geographic Atrophy: A 12-Month Post Hoc Analysis of the GATHER1 and GATHER2 Trials.

Journal: Ophthalmology. Retina

Published: August 24, 2023

Private equity ownership of ophthalmology practices: how does it impact clinical research?

Private equity ownership of ophthalmology practices: how does it impact clinical research?

Journal: Current opinion in ophthalmology

Published: August 02, 2022

Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.

Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.

Journal: JAMA ophthalmology

Published: June 16, 2022

Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration.

Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration.

Journal: Ophthalmology

Published: February 09, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026